A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases OnlyJohanna C. Bendell, Anthony A. Meluch, James D. Peyton et al.|The Oncologist|2016Cited by 20